Lithuania: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Lithuania

The Lithuanian prophylactic medicaments containing insulin market reduced to $X in 2022, shrinking by -7.9% against the previous year. Overall, consumption, however, showed a relatively flat trend pattern. Over the period under review, the market hit record highs at $X in 2018; however, from 2019 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Lithuania

In value terms, prophylactic medicaments containing insulin production dropped to $X in 2022 estimated in export price. Overall, production saw a relatively flat trend pattern. The growth pace was the most rapid in 2014 with an increase of 26%. As a result, production reached the peak level of $X. From 2015 to 2022, production growth remained at a lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Lithuania

In 2022, exports of medicaments containing insulin but not antibiotics in measured doses from Lithuania reduced rapidly to X tons, dropping by -90.9% compared with 2021 figures. Over the period under review, exports faced a abrupt setback. The most prominent rate of growth was recorded in 2015 with an increase of 25%. Over the period under review, the exports hit record highs at X tons in 2017; however, from 2018 to 2022, the exports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin exports contracted sharply to $X in 2022. In general, exports continue to indicate a drastic downturn. The growth pace was the most rapid in 2017 when exports increased by 19%. As a result, the exports reached the peak of $X. From 2018 to 2022, the growth of the exports failed to regain momentum.

Exports by Country

The Netherlands (X tons), Germany (X kg) and the Czech Republic (X kg) were the main destinations of prophylactic medicaments containing insulin exports from Lithuania, together accounting for 87% of total exports.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by the Netherlands (with a CAGR of +58.9%), while the other leaders experienced more modest paces of growth.

In value terms, the Netherlands ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Lithuania, comprising 59% of total exports. The second position in the ranking was held by Germany ($X), with a 21% share of total exports. It was followed by the Czech Republic, with a 9.9% share.

From 2012 to 2022, the average annual growth rate of value to the Netherlands totaled +75.3%. Exports to the other major destinations recorded the following average annual rates of exports growth: Germany (-4.0% per year) and the Czech Republic (+25.2% per year).

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, picking up by 144% against the previous year. Overall, the export price showed a remarkable increase. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices for the major external markets. In 2022, amid the top suppliers, the country with the highest price was the Netherlands ($X per ton), while the average price for exports to Belarus ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the Netherlands (+10.3%), while the prices for the other major destinations experienced a decline.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Lithuania

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses imported into Lithuania dropped remarkably to X tons, reducing by -30.5% compared with the year before. In general, imports recorded a perceptible decline. The pace of growth appeared the most rapid in 2015 with an increase of 23%. Over the period under review, imports attained the maximum at X tons in 2017; however, from 2018 to 2022, imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports contracted markedly to $X in 2022. Over the period under review, imports recorded a deep downturn. The most prominent rate of growth was recorded in 2020 with an increase of 18%. Over the period under review, imports reached the peak figure at $X in 2017; however, from 2018 to 2022, imports failed to regain momentum.

Imports by Country

In 2022, Latvia (X tons) constituted the largest prophylactic medicaments containing insulin supplier to Lithuania, with a 58% share of total imports. Moreover, prophylactic medicaments containing insulin imports from Latvia exceeded the figures recorded by the second-largest supplier, Germany (X tons), twofold. The Czech Republic (X tons) ranked third in terms of total imports with an 11% share.

From 2012 to 2022, the average annual growth rate of volume from Latvia stood at +52.3%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (+2.1% per year) and the Czech Republic (+80.3% per year).

In value terms, the largest prophylactic medicaments containing insulin suppliers to Lithuania were Latvia ($X), Germany ($X) and the Czech Republic ($X), together comprising 86% of total imports.

In terms of the main suppliers, Latvia, with a CAGR of +51.8%, saw the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, falling by -9.7% against the previous year. Over the period under review, the import price saw a noticeable descent. The growth pace was the most rapid in 2014 when the average import price increased by 12%. As a result, import price reached the peak level of $X per ton. From 2015 to 2022, the average import prices remained at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Slovenia ($X per ton), while the price for the Czech Republic ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Hungary (-0.2%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform